Avena targets U.S. market with scaled digital health infrastructure — TFN

Avena Applied sciences has processed greater than 4 million affected person consultations throughout a community of over fifteen thousand well being specialists in Mexico and Latin America. The corporate has been worthwhile and has grown primarily by way of bootstrapping since its seed spherical. Its purchasers embody Novo Nordisk and PepsiCo Well being and Diet Sciences. It was chosen for Bayer’s acceleration program. Now, the corporate is launching Alva Health in america.

Ruben Sandoval Davila, the co-founder and CTO who constructed the technical infrastructure behind these numbers, is main the platform’s adaptation for the U.S. market. Alva Well being, accessible at alvahealth.io, is designed as an AI-native hybrid care platform that embeds the medical structure Sandoval developed over a number of years of manufacturing deployment in Latin America right into a system constructed for American regulatory and workflow necessities.

“By embedding AI straight into the medical workflow, fairly than as a separate software, we cut back administrative overhead and enhance the variety of sufferers a single supplier can successfully handle,” Sandoval stated. “At scale, this adjustments entry to care.”

The platform Sandoval constructed operates on a mannequin he describes as hybrid AI-human care. The system automates documentation, scheduling, plan technology, and billing whereas retaining human specialists within the loop on the medical touchpoints the place their judgment and affected person rapport produce the strongest outcomes. The mannequin produces long-term affected person retention charges which can be, by the requirements of shopper digital well being, uncommon. In an business the place most apps lose nearly all of their customers inside weeks, Avena’s hybrid method has stored sufferers engaged for durations measured in months and years fairly than days. That sturdiness represents a qualitatively totally different sort of product, and it’s the metric that enterprise patrons consider most intently.

The enterprise relationships validate the mannequin at institutional scale. Engagements with world organisations resembling Novo Nordisk have required the platform to satisfy excessive requirements for compliance and knowledge governance. PepsiCo Well being and Diet Sciences engaged Avena for shopper well being initiatives. Bayer’s acceleration program choice concerned technical and business analysis by one of many world’s largest life sciences corporations. These usually are not pilot packages or letters of intent. They’re energetic business engagements with organisations that apply critical diligence to the platforms they undertake.

The exterior validation behind the corporate accrued regularly over the higher a part of a decade. Sandoval’s first worldwide recognition got here in 2014, when he gained first place at BBVA’s InnovaChallenge MX, a developer competitors judged by senior engineers from Google and BBVA, beating out 378 entrants from 36 international locations. A second-place end at BBVA InnovaApps+ adopted six months later. Google chosen Avena for its Google for Startups Accelerator for Latino Founders in 2022. Apple’s editorial group independently named the app its App of the Day and positioned it on its Hecho en Mexico checklist. Google did the identical by way of its personal featured apps program.

Taken individually, any one in every of these could be a footnote. Taken collectively, they describe one thing more durable to duplicate: a sample of impartial technical analysis, from establishments with no monetary stake within the end result, arriving at constantly optimistic assessments of Sandoval’s engineering work throughout totally different merchandise and totally different years. The path predates the present AI funding cycle by practically a decade, which suggests it can’t be attributed to hype.

The corporate has been worthwhile and has grown primarily by way of operational income since its preliminary seed spherical, a trajectory that’s unusual in digital well being, the place most corporations burn by way of a number of rounds of enterprise capital earlier than reaching sustainability. Avena’s path to profitability displays each the effectivity of the hybrid mannequin and the business self-discipline Sandoval and his co-founder have maintained as the corporate scaled.

Sandoval’s function within the U.S. launch is particularly architectural. He’s accountable for adapting the platform’s knowledge infrastructure and medical workflow techniques to the regulatory surroundings that governs digital well being in america. He’s main the design of what the group calls the Agent-Human care mannequin for Alva Well being, a framework that determines how AI and human suppliers work together throughout the platform’s medical workflows. And he’s representing the corporate in technical and enterprise engagements with U.S. enterprise companions, a operate that requires the flexibility to speak each the product’s medical structure and its business logic to institutional patrons.

The U.S. digital well being market is massive, crowded, and skeptical of newcomers. What Sandoval brings to it’s not a prototype or a pitch. It’s a production-tested structure that has already processed tens of millions of medical interactions, served hundreds of well being specialists, retained sufferers at charges that the majority shopper well being platforms can’t match, and earned the boldness of enterprise purchasers with world reputations. The technical infrastructure exists. The business relationships are energetic. The regulatory adaptation work is underway.

Alva Well being enters the U.S. market at a second when the dialog round AI in healthcare is dominated by corporations promising to automate medical care totally. Sandoval’s platform is constructed on a special premise, one validated by years of manufacturing knowledge, that the best medical AI is the type that makes a human specialist extra productive fairly than the type that replaces one. Whether or not the American market is prepared for that argument could rely on what number of totally automated well being platforms fail to retain their customers first.

Whether or not the structure interprets to the U.S. market is an open query. American healthcare regulation, reimbursement buildings, and shopper expectations differ meaningfully from these in Mexico and Latin America. Rivals with deeper home networks and current supplier relationships is not going to cede the market simply. Sandoval is conscious of this. He says the benefit is just not geographic familiarity however the manufacturing knowledge beneath the platform, 4 million consultations’ price of proof about what works and what doesn’t, accrued over years wherein most American digital well being corporations have been nonetheless elevating their Sequence A.

The U.S. launch, by way of Alva Well being, is the subsequent check. Sandoval enters it with a system that has already been examined at scale, not in a lab or a pilot, however within the day by day medical workflows of hundreds of well being specialists treating actual sufferers. That could be a more durable credential to fabricate than a fundraising announcement, and a more durable one to dismiss.